Physician profile
Eskender Beyene
NPI 1982642518
$4,394.87
in general payments reported to CMS, 2019-2025
6 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what 79% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $117 · 2021: $1,888 · 2022: $777 · 2023: $21.10 · 2024: $290 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $739 · Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $739.09 |
| Food and Beverage | $677.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,584.64 | 2020-2025 | Inspire |
| Zoll Respicardia, INC. | $596.15 | 2022-2023 | Remede System |
| Pfizer INC. | $100.00 | 2019 | |
| Philips North America LLC | $96.23 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.85 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$165,757.79 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eskender Beyene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.